Company Overview and News
BOSTON (Reuters) - For three years, the mutual funds in Fidelity’s flagship retirement franchise have outperformed at least 85 percent of their competitors, reversing a decade-long trend of subpar performance.
STOCKHOLM, Feb 7 (Reuters) - Swedish industrial technology firm Hexagon on Wednesday reported fourth-quarter core earnings ahead of analyst forecasts and said like-for-like sales growth had picked up sharply from the previous quarter.
Dassault Systemes has announced the availability of Electro Mobility Accelerator in India at the Auto Expo 2018. The solutions aims to provide industry-proven capabilities to develop new Electric Vehicle ideas, virtually simulate and validate performance, and ensure flexible, lean manufacturing.
Dassault Systemes expects a strong start to 2018 after fourth quarter revenue from new licences grew by a better-than-expected 16 percent, boosted by growth in its mid-market product design software Solidworks.
European stocks kicked off February in an upbeat fashion, rising for the first time in four days after a bout of well-received earnings, particularly from the financial and technology sectors.
The report, now available on ASDReports, "Simulation Software Market by Component (Software and Services), Application, Vertical (Automobile, Aerospace & Defense, Electrical & Electronics, Healthcare, and Education & Research), Deployment Mode and Region - Global Forecast to 2022", MarketsandMarkets expects the global simulation software market to grow from USD 6.26 Billion in 2017 to USD 13.45 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 16.
Investors are always looking for stocks that are poised to beat at earnings season and Dassault Systèmes SE (DASTY - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report. That is because Dassault is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Thank you for standing by and welcome to the Dassault Systèmes and Exa Corporation September 28, 2017 Conference Call. At this time, all participants are in a listen-only mode. A short overview will be given followed by a question-and-answer session. [Operator Instructions] I must advise you that this conference is being recorded today.
PARIS (Reuters) - French software company Dassault Systemes (DAST.PA) has agreed to buy U.S. peer Exa Corp (EXA.O) in a deal valued at about $400 million, which Dassault said would boost its range of products for clients.
MicroStrategy Incorporated (MSTR - Free Report) is a leading worldwide provider of business intelligence software, today announced that GT Nexus has selected MicroStrategy to power the customer-facing analytics and reporting capabilities on its Global Logistics portal. The GT Nexus portal is an on demand technology platform that is used by importers, exporters, transportation carriers, suppliers, banks, and other partners to manage goods that are moving around the world.
2018-04-23 - Asif
Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...